Skip to main content
. 2017 May 2;3:2333721417708071. doi: 10.1177/2333721417708071

Table 1.

Characteristics of the Participants in the Study.

Variables All Healthy group Hypertensive group Coronary artery disease group p value
Number 45 27 11 7
Sex (male) 18 (40.0) 6 (22.2) 7 (63.6) 5 (71.4) .011
Age (years) 73.6 ± 5.7 71.7 ± 4.8 74.5 ± 6.2 79.3 ± 4.3 .004
Height (cm) 157.4 ± 8.8 155.7 ± 8.5 159.9 ± 8.4 160.3 ± 10.1 .262
Weight (kg) 56.6 ± 10.6 53.5 ± 10.9 62.4 ± 7.8 59.5 ± 9.8 .045
BMI (kg/m2) 22.7 ± 2.9 21.9 ± 2.7 24.5 ± 3.3 23.0 ± 2.3 .046
HT 15 (33.3) 0 11 (100) 4 (57.1)
CAD (NYHA Class I at most) 7 (15.6) 0 0 7 (100)
HL 12 (26.7) 8 (29.6) 3 (27.3) 1 (14.3) .715
Medication
 ARB 11 (24.4) 0 8 (72.7) 3 (42.9)
 ACE inhibitor 1 (2.2) 0 1 (9.1) 0
 Ca blocker 8 (17.8) 0 5 (45.5) 3 (42.9)
 Statin 11 (24.4) 6 (22.2) 2 (18.2) 3 (42.9) .451
Systolic BP (mmHg) 121.9 ± 12.1 121.5 ± 13.2 122.6 ± 10.3 122.3 ± 11.8 .965
Diastolic BP (mmHg) 69.5 ± 8.4 70.7 ± 7.6 68.5 ± 9.1 66.7 ± 10.4 .490
RR (cycles/minute) 13.8 ± 1.3 13.7 ± 1.3 14.2 ± 1.3 14.0 ± 1.0 .326
HR (bpm) 66.1 ± 9.6 65.0 ± 8.9 68.3 ± 11.8 67.0 ± 9.2 .616
LF (msec2/Hz) 11.9 (7.6–22.3) 12.4 (8.9–22.4) 11.8 (6.5–18.2) 9.0 (6.7–23.8) .875
HF (msec2/Hz) 15.7 (8.4–34.7) 22.6 (10.0–35.6) 11.3 (5.1–17.4) 21.5 (12.3–36.7) .262
LF/HF 0.90 (0.45–2.03) 0.64 (0.39–1.40) 1.11 (0.80–2.04) 1.46 (0.74–2.66) .163

Note. Categorical variables are presented in absolute numbers and percentages. Continuous variables are expressed as mean and standard deviation or median and interquartile range. BMI = body mass index; HT = hypertension; CAD = coronary artery disease; NYHA = New York Heart Association; HL = hyperlipidemia; ARB = angiotensin II receptor blocker; ACE = angiotensin converting enzyme; Ca blocker = calcium channel blocker; BP = blood pressure; RR = respiratory rate; HR = heart rate; LF = low frequency component; HF = high frequency component; LF/HF = the ratio of LF to HF.